Novel method for facial rejuvenation using Er:YAG laser equipped with a spatially modulated ablation module: An open prospective uncontrolled cohort study

Journal of Cosmetic and Laser Therapy

19:1, 25-29, DOI: 10.1080/14764172.2016.1247964

N.V. Volkovaa, L.K. Glazkovab, V.V. Khomchenkoc and N.S. Sadickd

aDermatologist, Aesthetic Laser Clinician, Aesthetic Medicine Department, Ural State Medical University, Ekaterinburg, Russia;
bdDermatologist, Department of Skin Diseases, Aesthetic Medicine Department, Ural State Medical University, Ekaterinburg, Russia;
cHead of Research and Development, Director of LINLINE Medical Systems, Developer of the RecoSMA Technology, Minsk, Republic of Belarus;
dDermatology, Weill Cornell Medical College, President of Sadick Dermatology, New York, New York, USA

Read the full article


Facial aging is a complex biological process that a ects the skin and super cial musculoaponeurotic system (SMAS). A new technology (RecoSMA) for skin rejuvenation based on acoustic-interference method using Er:YAG laser (2936 nm) equipped with a special module SMA that targets both the dermis and SMAS was evaluated in an open-label prospective cohort study of 100 female patients treated for facial rejuvenation. Measure of clinical improvement included investigator-rated clinical photography using the Modi ed Fitzpatrick Wrinkle Scale, and ultrasound measurements in the dermis a week, 30 days and six months post treatment. All patients completed the study and no complications were noted. Improvements in skin tone and texture were noted in all participants and signi cant decrease in wrinkle depth was demonstrated at the six-month follow-up that was con rmed by ultrasound skin measurements. Data presented herein con rm the safety and e cacy of RecoSMA treatment for facial rejuvenation.

Comments are closed.